|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||4.1800 - 4.2500|
|52 Week Range||4.1800 - 4.2500|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
How far off is Avid Bioservices Inc (NASDAQ:CDMO) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock isRead More...
On a per-share basis, the Tustin, California-based company said it had a loss of 28 cents. Losses, adjusted to account for discontinued operations, came to 23 cents per share. The pharmaceutical posted ...
In this article, I’m going to take a look at Avid Bioservices Inc’s (NASDAQ:CDMO) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject amongRead More...
When Avid Bioservices Inc (NASDAQ:CDMO) released its most recent earnings update (31 October 2017), I compared it against two factor: its historical earnings track record, and the performance of itsRead More...
Peregrine Pharmaceuticals (PPHM) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and year.
Stock Monitor: Peregrine Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 18, 2017 / Active-Investors issued a free report on Mesoblast Ltd (NASDAQ: MESO ), which is readily accessible ...